Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

Jun 10, 2020

SELL
$37.9 - $104.44 $107,067 - $295,043
-2,825 Closed
0 $0
Q3 2019

Oct 18, 2019

SELL
$90.37 - $122.49 $151,369 - $205,170
-1,675 Reduced 37.22%
2,825 $255,000
Q3 2018

Oct 17, 2018

BUY
$48.29 - $80.6 $217,305 - $362,700
4,500 New
4,500 $355,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $10.3B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Coastline Trust CO Portfolio

Follow Coastline Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coastline Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Coastline Trust CO with notifications on news.